European Association of Myasthenia Gravis Patients' Associations
Home
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology
Myasthenia Gravis and Related Disorders - ScienceDirect
Myasthenia Gravis – from weakness shall come strength
Medical IDs for Myasthenia Gravis | MedicAlert Foundation
Myasthenia gravis, castleman disease, pemphigus, and anti‐phospholipid syndrome - Jakubíková - 2013 - Muscle & Nerve - Wiley Online Library
Myasthenia Gravis – from weakness shall come strength
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis - Uzawa - 2021 - Clinical & Experimental Immunology - Wiley Online Library
The humanistic burden of myasthenia gravis: A systematic literature review - ScienceDirect
NOVÉ SILIKONOVÉ NÁRAMKY - Novinky - MYGRA-CZ
B cells in the pathophysiology of myasthenia gravis - Yi - 2018 - Muscle & Nerve - Wiley Online Library
PDF) Pneumonia in myasthenia gravis: Microbial etiology and clinical management
Biomedicines | Free Full-Text | Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
Frontiers | Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
Frontiers | Immunoregulatory Cells in Myasthenia Gravis
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK | PLOS ONE
Mortality rates and causes of death in Swedish Myasthenia Gravis patients - ScienceDirect
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK | PLOS ONE
